Collagen External Scaffolds Mitigate Intimal Hyperplasia and Improve Remodeling of Vein Grafts in a Rabbit Arteriovenous Graft Model

Objectives. The aim of this study was to test the effects of collagen external scaffold (CES) in intimal hyperplasia of vein grafts and explore its underlying mechanisms. Methods. Thirty-six New Zealand white rabbits were randomized into no-graft group, graft group, and CES group. The rabbit arteriovenous graft model was established. In CES group, the vein graft was wrapped around with CES. The hemodynamic parameters of vein grafts were measured intraoperatively and 4 weeks after operation by ultrasonic examination. Histological characteristics of vein grafts were also evaluated 4 weeks later. The mRNA and protein levels of proliferating cell nuclear antigen (PCNA), active cleaved-caspase-3 (ClvCasp-3), and smooth muscle 22 alpha (SM22α) were measured 4 weeks later by quantitative real-time PCR and western blot. Results. CES significantly improved the hemodynamic stability of vein grafts, with higher blood velocity and blood flow. Similarly, CES also markedly mitigated intimal hyperplasia and inhibited dilatation of vein grafts. In CES group, the upexpression of PCNA and ClvCasp-3 and the downexpression of SM22α were inhibited. Conclusion. CES exerts beneficial effects in mitigating intimal hyperplasia and improving remodeling of autogenous vein grafts, which may be associated with reducing the proliferation and apoptosis and preserving the phenotype of VSMCs.

[1]  Yonggang Lv,et al.  Application of Collagen Scaffold in Tissue Engineering: Recent Advances and New Perspectives , 2016, Polymers.

[2]  C. Gu,et al.  Perivenous application of cyanoacrylate tissue sealants reduces intimal and medial thickening of the vein graft and inflammatory responses in a rabbit model of carotid artery bypass grafting. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  E. Shi,et al.  Inhibition of intimal hyperplasia of the vein graft with degradable poly lactic-co-glycolic acid vascular external sheaths carrying slow-release bosentan. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[4]  Shuddhadeb Ray,et al.  Pore size and pore shape--but not mesh density--alter the mechanical strength of tissue ingrowth and host tissue response to synthetic mesh materials in a porcine model of ventral hernia repair. , 2015, Journal of the mechanical behavior of biomedical materials.

[5]  C. Brophy,et al.  Surgical vein graft preparation promotes cellular dysfunction, oxidative stress, and intimal hyperplasia in human saphenous vein. , 2014, Journal of vascular surgery.

[6]  D. Agrawal,et al.  Coronary artery bypass graft: why is the saphenous vein prone to intimal hyperplasia? , 2014, Canadian journal of physiology and pharmacology.

[7]  J. Haefliger,et al.  The use of external mesh reinforcement to reduce intimal hyperplasia and preserve the structure of human saphenous veins. , 2014, Biomaterials.

[8]  F. Lundgren.  External support of a polytetrafluoroethylene graft improves patency for bypass to below-knee arteries. , 2013, Annals of vascular surgery.

[9]  C. Milano,et al.  Gene therapy for the prevention of vein graft disease. , 2013, Translational research : the journal of laboratory and clinical medicine.

[10]  Xinhua Hu,et al.  Transfected Early Growth Response Gene-1 DNA Enzyme Prevents Stenosis and Occlusion of Autogenous Vein Graft In Vivo , 2013, BioMed research international.

[11]  S. Wan,et al.  External support in preventing vein graft failure , 2012, Asian cardiovascular & thoracic annals.

[12]  K. Kent,et al.  Protein Kinase C-Delta Mediates Adventitial Cell Migration Through Regulation of Monocyte Chemoattractant Protein-1 Expression in a Rat Angioplasty Model , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[13]  Shu-ming Wu,et al.  [Pretreatment of isolated vein with rapamycin nanoparticles inhibits vein graft stenosis in rabbits]. , 2011, Zhonghua yi xue za zhi.

[14]  A. Dardik,et al.  Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[15]  J. Haefliger,et al.  An angiotensin II- and NF-kappaB-dependent mechanism increases connexin 43 in murine arteries targeted by renin-dependent hypertension. , 2010, Cardiovascular research.

[16]  A. Seifalian,et al.  Inhibition of neointimal formation and hyperplasia in vein grafts by external stent/sheath , 2010, Vascular medicine.

[17]  Jacco van Rheenen,et al.  Collagen-based cell migration models in vitro and in vivo. , 2009, Seminars in cell & developmental biology.

[18]  R. Arora,et al.  Coronary vein graft disease: pathogenesis and prevention. , 2009, The Canadian journal of cardiology.

[19]  T. Hohlfeld,et al.  Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[20]  K. Martin,et al.  Regulation of vascular smooth muscle cell differentiation. , 2007, Journal of vascular surgery.

[21]  G. Angelini,et al.  On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents. , 2007, Biomaterials.

[22]  Prevent Iv Investigators.  Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. , 2005 .

[23]  G. Moneta,et al.  Design and Rationale of the PREVENT III Clinical Trial: Edifoligide for the Prevention of Infrainguinal Vein Graft Failure , 2005, Vascular and endovascular surgery.

[24]  D. Herbage,et al.  Collagen-based biomaterials as 3D scaffold for cell cultures: applications for tissue engineering and gene therapy , 2000, Medical and Biological Engineering and Computing.

[25]  W J Keon,et al.  Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. , 1996, Journal of the American College of Cardiology.

[26]  Y. Saijo,et al.  A novel biodegradable external mesh stent improved long-term patency of vein grafts by inhibiting intimal–medial hyperplasia in an experimental canine model , 2015, General Thoracic and Cardiovascular Surgery.

[27]  W. Marsden.  I and J , 2012 .

[28]  R. Califf,et al.  Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. , 2005, JAMA.